Method Comparison of Intelligent Fingerprinting Drug Screening System

Conditions

• In Vitro Diagnostic Device

Eligibility Criteria

Sex

ALL

Age

18 Years - 65 Years

Healthy Volunteers

Accepted

Interventions

• Diagnostic Test — DEVICE
  Measurement of codeine in human fingerprint sweat

Study Details

Prospective, multi-site, open-label, single- or double-dose, randomized, multi-site performance evaluation of accuracy of the Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."

Key Dates

First listed

Jun 16, 2026

Start date

Jun 2, 2026

Status verified

Jun 2026

Primary completion

Jul 31, 2026

Completion

Aug 31, 2026

Study Design

Enrollment

144 participants (estimated)

Arms

• Arm: Undosed
  No codeine administered
• Arm: Dosed
  2 doses of codeine administered in tablet form, 60 mg per dose

Primary Outcome Measure

Sensitivity [ Time Frame: 24 hrs ]

Central Contacts

• Elan Cohen, PhD
  856.452.9901
  [email protected]

Locations (1)

Find similar trials in Marlton, NJ